Pancreatic Neoplasm Clinical Trials

68 clinical trials for Pancreatic Neoplasm across international registries, including 18 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of LY4170156 in Participants With Selected Advanced Solid Tumors — RECRUITING · PHASE1
• Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers — RECRUITING · NA
• A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression — RECRUITING · PHASE1
• Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals — RECRUITING · PHASE1
• Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors — RECRUITING · PHASE1
• Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery — RECRUITING · NA
• Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula — RECRUITING · PHASE3
• Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study — RECRUITING · NA
• Endoscopic Ultrasound Radiofrequency Ablation, Database Repository — RECRUITING
• MRE for Diagnosis of Pancreatic Masses — RECRUITING
• Endocrine-exocrine Functions and Prognosis After Pancreatectomy — RECRUITING
• Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy — RECRUITING · PHASE2
• Delayed Gastric Emptying After Pancreatic Surgery — RECRUITING
• Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer — RECRUITING · PHASE2
• DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations — RECRUITING · PHASE2
• MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer — RECRUITING
• OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. — RECRUITING
• Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma — RECRUITING · PHASE2
• Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer — COMPLETED · PHASE1
• Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms — NOT_YET_RECRUITING · NA
• Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes — COMPLETED
• Prediction Model of Pancreatic Neoplasms in CP Patients With Focal Pancreatic Lesions — COMPLETED
• Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study — COMPLETED · PHASE2
• Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm — WITHDRAWN · NA
• DDP ip Combined With AG in PDAC With Peritoneal Metastasis — COMPLETED · PHASE2
• A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma — TERMINATED · PHASE1
• A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients — WITHDRAWN · PHASE2
• Pancreatic Cancer Dietary Assessment Study — COMPLETED
• Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) — COMPLETED · PHASE1
• Cancer Stem Cell Specific Aptamer's Ability to Detect Blood Circulating Cancer Stem Cells and Its Role as a Predictor of Prognosis in Pancreatic Cancer — COMPLETED
• CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With Radiotherapy — COMPLETED · NA
• Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic Neoplasms — OTHER · NA
• Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer — OTHER · PHASE2
• Cancer of the Pancreas Screening Study (CAPS 3) — COMPLETED
• Percutaneous Versus EUS FNAC in Pancreatic Masses — OTHER · NA
• Comparison of EUS-FNB Biopsy Techniques of Solid Pancreatic Lesions — OTHER · NA
• EUS-FNB for Solid Pancreatic Lesions: Side-fenestrated Vs Fork-tip Needle — COMPLETED · NA
• Evaluation of Difficulty Score for Robotic Pancreatoduodenectomy — OTHER · NA
• EUS-FNB With ROSE Vs. EUS-FNB Without ROSE — COMPLETED · NA
• Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer — COMPLETED · PHASE2
• Trial Comparing 19 and 25-gauge EUS-FNA Needles — COMPLETED · NA
• Impact of Suction in the EUS-guided Fine Needle Biopsy of Solid Pancreatic Lesions — OTHER · NA
• Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle — COMPLETED · NA
• Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses — COMPLETED · NA
• Comparing Biopsy Needles for Endoscopic Ultrasound Guided Samples for Pancreatic Masses — COMPLETED · NA
• Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer — COMPLETED · PHASE2
• The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial. — COMPLETED · NA
• 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients — TERMINATED · PHASE1
• 22G FNA Needle vs. 22G ProCore Needle — COMPLETED · NA
• Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients — TERMINATED

Refine this search